Cobalamin Used in Chronic Fatigue Syndrome Therapy Is a Nitric Oxide Scavenger

References

• Gantz NM, Holmes GP: Treatment of patients with chronic fatigue syndrome. Drugs 1989;38:855–862.
   PubMed Web of Science ®Google Scholar
• Lapp CW: Using vitamin B-12 for the management of CFS. The CFIDS Chroni-cle 1999;12(6):14–16.
   Google Scholar
• Hoh, D: Treatment at the Cheney clinic. The CFIDS Chronicle 1998;11(4)13–14.
   Google Scholar
• Björkegren K: Vitamin B12, chronic fatigue and injection treatment Lakartidningen 1999;96: 5610.
   Google Scholar
• Wiebe E: N of trials. Managing patients with chronic fatigue syndrome: Two case reports. Can Fam Physician 1996;42:2214–2217.
   Google Scholar
• Pall ML: Elevated peroxynitrite as the cause of chronic fatigue syndrome. Medi-cal Hypoth 2000;54:115–125.
   PubMed Web of Science ®Google Scholar
• Pall ML: Elevated peroxynitrite as the cause of chronic fatigue syndrome: Other inducers and mechanisms of symptom generation. J Chronic Fatigue Syndrome, 2000; 7(4):45–58.
   Google Scholar
• Werner ER, Werner-Felmayer G, Wachter H: Tetrahydrobiopterin and cytokines. Proc Soc Exp Biol Med 1993;203:1–12.
   PubMed Web of Science ®Google Scholar
• Werner ER, Werner-Felmayer G, Fuchs D, et al.: Biochemistry and function of pteridine synthesis in human and murine macrophages. Macrophage 1990;59: 276–279.
   Google Scholar
• Wachter H, Fuchs D, Hausen A, et al.: Neopterin Biochemistry-Methods-Clin-ical Application. Berlin, Walter De Gruyter, 1992.
   Google Scholar
• Chao CC, Gallagher M, Phair J, Peterson PK: Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis 1990;162:1412–1413.
   PubMed Web of Science ®Google Scholar
• Matsuda J, Gohchi K, Gotoh N: Serum concentrations of 29,59-oligoadenylate synthetase, neopterin, and beta-glucan in patients with chronic fatigue syndrome and in patients with major depression. J Neurol Neurosurg Psychiatry 1994;57:1015–1016.
   PubMed Web of Science ®Google Scholar
• Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA: Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 1994;18:S147–S153.
   PubMed Web of Science ®Google Scholar
• Linde A, Andersson B, Svenson SB, et al.: Serum levels of lymphokines and soluble cellular receptors in primary Epstein-Barr virus infection and in patients with chronic fatigue syndrome. J Infect Dis 1992;165:994–1000.
   Google Scholar
• Buchwald D, Wener MH, Pearlman T, Kith P: Markers of inflammation and im-mune activation in chronic fatigue syndrome. J Rheumatol 1997;24:372–376.
   PubMed Web of Science ®Google Scholar
• Chao CC, Janoff EN, Hu S, Thomas TW, Gallagher M, Peterson PK: Altered cytokine release in peripheral blood mononuclear cell cultures from patients with chronic fatigue syndrome. Cytokine 1991;3:292–298.
   PubMed Web of Science ®Google Scholar
• Gupta S, Aggarwal S, See D, Starr A: Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res 1997; 31:149–156.
   PubMed Web of Science ®Google Scholar
• Cannon JG, Angel JB, Abad LW, et al.: Interleukin-1, interleukin-1 receptor antagonist and soluble interleukin-1 receptor type II secretion in chronic fatigue syn-drome. J Clin Immunol 1997;17: 253–261.
   Google Scholar
• Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP: Elevation of plasma cytokines in disorders of excessive daytime sleepiness: Role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313–1316.
   PubMed Web of Science ®Google Scholar
• Cannon JG, Angel JB, Ball RW, et al.: Acute phase responses and cytokine se-cretion in chronic fatigue syndrome. J Clin Imuunol 1999;19:414–421.
   Google Scholar
• Borish L, Schmaling K, DiClementi JD, et al.: Chronic fatigue syndrome: Iden-tification of distinct subgroups on the basis of allergy and psychologic variables. J Al-lergy Clin Immunol 1998;102:222–230.
   Google Scholar
• Penttila IA, Harris RJ, Storm P, et al.: Cytokine dysregulation in the post-Q-fever fatigue syndrome. QJM 1998;91:549–560.
   Google Scholar
• Moss RB, Mercandetti A, Vojdani A: TNF a and chronic fatigue syndrome. J Clin Immunol 1999;19:314–316.
   PubMed Web of Science ®Google Scholar
• Rochelle LG, Morana Si, Kruszyna H, et al.: Interactions between hydroxo-cobalamin and nitric oxide (NO): Evidence for a redox reaction between NO and re-duced cobalamin and reversible NO binding to oxidized cobalamin. J Pharmacol Expt Therapeut 1995;275:48–52.
   Google Scholar
• Rajanayagam MAS, Li CG, Rand MJ: Differential effects of hydroxocobalamin in NO-medicated relaxations of rat aorta and anococcygeus muscle. Br J Pharmacol 1993;108:3–5.
   PubMed Web of Science ®Google Scholar
• Greenberg SS, Xie J, Zatarain JM, Kapusta DR, Miller MJ: Hydroxocobalamin (vitamin B12a) prevents and reverses endotoxin-induced hypotension in rodents: Role of nitric oxide. J Pharmacol Exp Ther 1995;273:257–265.
   PubMed Web of Science ®Google Scholar
• Ding Y, McCoubrey WK Jr, Maines MD: Interaction of heme oxygenase-2 with nitric oxide donors: Is the oxygenase an intracellular "sink" for NO? Eur J Biochem 1999;264:854–861.
   PubMedGoogle Scholar
• Foresti R, Clark JE, Green CJ, Motterlini R: Thiol compounds interact with ni-tric oxide in regulating heme oxygenase-1 induction in endothelial cells. Involvement of superoxide and peroxynitrite anions. J Biol Chem 1997;272:18411–18417.
   Google Scholar
• Mellman I, Willard DF, Youngdahl-Turner P, Rosenberg LE: Cobalamin coenzyme synthesis in normal and mutant human fibroblasts: Evidence for a process-ing enzyme activity deficient in cbl C cells. J Biol Chem 1979;254:11847–11854.
   PubMed Web of Science ®Google Scholar
• Regland B, Andersson M, Abrahamsson L, et al.: Increased concentration of homocysteine in the cerebrospinal fluid in patients with chronic fatigue syndrome and fibromylagia. Scand J Rheumatol 1997;26:301–307.
   Google Scholar
• Nicolau A, Waterfield CJ, Kenyon SH, Gibbons WA: The inactivation of methionine synthase in isolated rat hepatocytes by sodium nitroprusside. Eur J Biochem 1997;244:876–882.
   PubMedGoogle Scholar
• Kinsella LJ, Green R: "Anesthesia paresthetica": Nitrous oxide-induced cobalamin deficiency. Neurology 1995;45:1608–1610.
   PubMed Web of Science ®Google Scholar
• Riedel B, Fiskerstrand T, Refsum H, Ueland PM: Co-ordinate variations in methylmalonyl-CoA mutase and methionine synthase, and the cobalamin cofactors in human glioma cells during nitrous oxide exposure during nitrous oxide exposure and subsequent recovery phase. Biochem J 1999;341:133–138.
   PubMed Web of Science ®Google Scholar
• Marie RM, Le Biez E, Busson P, et al.: Nitrous oxide anesthesia-associated myelopathy. Arch Neurol 2000;57:380–382.
   PubMed Web of Science ®Google Scholar
• Kaczka EA, Wolf DE, Kuehl FA Jr, Folker K: Vitamin B12 XVI. Modification of cyanocobalamin. J Am Chem Soc 1951;73:3569–3572.
   Web of Science ®Google Scholar
• Karnad AB, Krozser-Hamati A: Pernicious anemia. Early identification to pre-vent permanent sequelae. Porstgrad Med 1992;91(2):231–237.
   Google Scholar
• Kamaze DS, Carmel R: Neurologic and evoked potential abnormalities in sub-tle cobalamin deficiency states, including deficiency without anemia and with normal absorption of cobalamin. Arch Neurol 1990;47:1008–1012.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Straus SE, Hickie I, et al.: The chronic fatigue syndrome: A compre-hensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Aim Intern Med 1994;121:953–959.
   PubMed Web of Science ®Google Scholar